tick-borne encephalitis virus neudorfl strain

Poland

Drugs containing this active substance

  • FSME-IMMUN 0.25 ML JUNIOR

    The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for children aged 1 to 15 years.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    aluminum hydroxide hydrate 0,17 mg
    tick-borne encephalitis virus neudorfl strain 1.2 mcg

    ATC: J07BA01

    Manufacturer: Pfizer Manufacturing Belgium NV

  • The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for individuals aged 16 years and older.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    tick-borne encephalitis virus neudorfl strain 2.4 mcg/0.5 ml

    ATC: J07BA01

    Manufacturer: Pfizer Manufacturing Belgium NV